首页|血清YKL-40、FGF21与尿毒症患者营养不良-炎症-动脉粥样硬化综合征的关系

血清YKL-40、FGF21与尿毒症患者营养不良-炎症-动脉粥样硬化综合征的关系

扫码查看
目的 探讨血清人软骨糖蛋白-40(YKL-40)、成纤维细胞生长因子21(FGF21)水平与尿毒症患者营养不良-炎症-动脉粥样硬化综合征(MIAS)的关系.方法 选择2020年3月至2022年3月本院收治的186例尿毒症患者为研究对象,根据是否发生MIAS分为MIAS组(40例)和非MIAS组(146例).收集患者的临床资料,检测血清YKL-40、FGF21、白蛋白(ALB)、高敏C反应蛋白(hs-CRP)水平,采用颈动脉超声检测颈总动脉或分叉处的内膜中层厚度(IMT).采用Pearson相关性分析YKL-40、FGF21与ALB、hs-CRP、IMT的相关性,多因素logistic回归分析影响尿毒症患者发生MIAS的危险因素,受试者工作特征(ROC)曲线分析YKL-40、FGF21鉴别尿毒症患者发生MIAS的价值.结果 MIAS组的血清YKL-40、FGF21水平均高于非MIAS组(均P<0.05).MIAS组的血清YKL-40、FGF21水平与hs-CRP、IMT呈正相关(均P<0.05),与ALB呈负相关(P<0.05).血液透析时间过长、高YKL-40、高FGF21是尿毒症患者发生MIAS的危险影响因素(均P<0.05).YKL-40、FGF21鉴别尿毒症患者发生MIAS的ROC曲线下面积为0.738、0.701,联合YKL-40、FGF21鉴别尿毒症患者发生MIAS的ROC曲线下面积为0.933,高于二者单独诊断(P<0.05).结论 尿毒症合并MIAS患者的血清YKL-40、FGF21水平显著增高,可能与MIAS的发生有关,检测血清YKL-40和FGF21有助于评估MIAS的风险.
Analysis of the relationship between serum YKL-40 and FGF21 levels and dystrophy-inflamma-tory-atherosclerosis syndrome in uremia patients
Objective To investigate the relationship between serum levels of chitinase-3-like protein 1(YKL-40)and fibroblast growth factor 21(FGF21)and malnutrition-inflammation-athero-sclerosis syndrome(MIAS)in patients with uremia.Methods A total of 186 uremia patients admitted to the department of nephrology of our hospital from March 2020 to March 2022 were selected and di-vided into MIAS group(40 cases)and non-MIAS group(146 cases)according to the occurrence of MIAS.Relevant clinical data were collected and serum levels of YKL-40,FGF21,albumin(ALB)and high-sensitivity C-reactive protein(hs-CRP)were detected.Carotid artery ultrasound was used to detect the intima-media thickness(IMT)of the common carotid artery or the branch.Pearson correla-tion analysis of YKL-40,FGF21 and ALB,hs-CRP,IMT.Multivariate logistic regression was used to analyze the risk factors of MIAS in uremia patients,and receiver operating characteristic curve(ROC)was used to analyze the value of YKL-40 and FGF21 in identifying MIAS in uremia patients.Results The levels of serum YKL-40 and FGF21 in MIAS group were higher than those in non-MIAS group(all P<0.05).Serum YKL-40 and FGF21 levels in MIAS group were positively correlated with hs-CRP and IMT(all P<0.05),and negatively correlated with ALB(P<0.05).Prolonged hemodialysis time,high YKL-40 and high FGF21 were risk factors for MIAS in uremia patients(all P<0.05).The area under the curve of YKL-40 and FGF21 in the identification of MIAS in uremia patients was 0.738 and 0.701,and the area under the curve of combined YKL-40 and FGF21 in the identification of MIAS in uremia patients was 0.933,which was higher than that of single diagnosis(P<0.05).Conclusions The levels of serum YKL-40 and FGF21 in uremic patients with MIAS increased significantly,which may be related to the occurrence of MIAS.The detection of serum YKL-40 and FGF21 is helpful to as-sess the risk of MIAS.

UremiaAtherosclerosisMalnutritionHuman Cartilage Glycoprotein 39Fibro-blast Growth Factor 21

丁红赟、刘容、林颖、崔小平

展开 >

重庆大学附属黔江医院肾内科,重庆 409000

尿毒症 动脉粥样硬化 营养不良 人软骨糖蛋白-39 成纤维细胞生长因子21

重庆市黔江区科技计划项目

2022026

2024

国际泌尿系统杂志
中华医学会,湖南省医学会

国际泌尿系统杂志

CSTPCD
影响因子:0.414
ISSN:1673-4416
年,卷(期):2024.44(4)